Literature DB >> 15742434

Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis.

Patrick H Dessein1, Barry I Joffe, Martin G Veller, Belinda A Stevens, Milton Tobias, Kogie Reddi, Anne E Stanwix.   

Abstract

OBJECTIVE: To determine the association between cardiovascular (CV) risk factors and atherosclerosis in patients with rheumatoid arthritis (RA).
METHODS: The common carotid artery intima-media thickness (IMT) and plaque were evaluated by high resolution B-mode ultrasound in 74 consecutive patients with RA. Patients with an IMT > or = 0.60 mm and plaque were considered to have atherosclerosis and advanced atherosclerosis, respectively. Traditional risk factors as well as an extensive range of other clinical and laboratory variables were recorded. Methods used to analyze the data included logistic regression, classification and regression tree (CART), and factor analyses.
RESULTS: Fifty-three (72%) patients had atherosclerosis, 23 (31%) had plaque, and 21 (28%) were free of atherosclerosis. In multivariable analysis, age and hypertension were independently associated with atherosclerosis and plaque (p < or = 0.04). Radiographic scores and polymorphonuclear cell counts were also strongly associated with plaque (p < or = 0.008). Uric acid concentrations were associated with atherosclerosis, and hypothyroidism was associated with plaque, both with borderline significance (p = 0.078 and 0.052, respectively). In CART analysis, age, polymorphonuclear cell counts, and joint space narrowing in the hands were considered to be the most important determinants of plaque, and 62% of patients could be classified correctly after cross-validation. Factor analysis (varimax rotation) revealed that age and uric acid levels were related to low glomerular filtration rates, polymorphonuclear cell counts to disease activity, and radiographic scores to disease duration, and hypertension was associated with high cholesterol levels. The 10-year risk for a coronary event estimated using the Framingham risk equation (calculated from traditional risk factors) was only 7% in patients with plaque.
CONCLUSION: Atherosclerosis in RA is associated with the traditional CV risk factors age and hypertension, as well as nontraditional risk factors comprising current inflammation as reflected by polymorphonuclear cell counts, cumulative inflammation as disclosed by radiographic scores, and, to a lesser extent, with uric acid levels and hypothyroidism. Multiple risk factor assessment equations that are based on traditional risk factors only are likely to be insufficient to capture CV risk extent in RA.

Entities:  

Mesh:

Year:  2005        PMID: 15742434

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  70 in total

1.  Inflammation and hypertension in rheumatoid arthritis.

Authors:  Siriporn Manavathongchai; Aihua Bian; Young Hee Rho; Annette Oeser; Joseph F Solus; Tebeb Gebretsadik; Ayumi Shintani; C Michael Stein
Journal:  J Rheumatol       Date:  2013-09-01       Impact factor: 4.666

2.  Cardiovascular injury in systemic autoimmune diseases: an update.

Authors:  Maurizio Turiel; Piercarlo Sarzi-Puttini; Fabiola Atzeni; Vito De Gennaro Colonna; Luigi Gianturco; Livio Tomasoni
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

3.  Statin therapy in rheumatoid arthritis: a cost-effectiveness and value-of-information analysis.

Authors:  Nick Bansback; Roberta Ara; Sue Ward; Aslam Anis; Hyon K Choi
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

4.  Impact of rheumatoid arthritis on receiving a diagnosis of hypertension among patients with regular primary care.

Authors:  Christie M Bartels; Heather Johnson; Katya Voelker; Carolyn Thorpe; Patrick McBride; Elizabeth A Jacobs; Nancy Pandhi; Maureen Smith
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-09       Impact factor: 4.794

5.  Modulation of autoimmune arthritis severity in mice by apolipoprotein E (ApoE) and cholesterol.

Authors:  P Alvarez; F Genre; M Iglesias; J J Augustin; E Tamayo; J C Escolà-Gil; B Lavín; F Blanco-Vaca; R Merino; J Merino
Journal:  Clin Exp Immunol       Date:  2016-10-04       Impact factor: 4.330

Review 6.  Novel risk factors for cardiovascular disease in rheumatoid arthritis.

Authors:  Jenny Amaya-Amaya; Juan Camilo Sarmiento-Monroy; Ruben-Dario Mantilla; Ricardo Pineda-Tamayo; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

Review 7.  Rheumatoid arthritis and metabolic syndrome.

Authors:  György Kerekes; Michael T Nurmohamed; Miguel A González-Gay; Ildikó Seres; György Paragh; Zsófia Kardos; Zsuzsa Baráth; László Tamási; Pál Soltész; Zoltán Szekanecz
Journal:  Nat Rev Rheumatol       Date:  2014-08-05       Impact factor: 20.543

Review 8.  Cardiovascular comorbidity in rheumatic diseases.

Authors:  Michael T Nurmohamed; Maaike Heslinga; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2015-08-18       Impact factor: 20.543

9.  Vascular function and inflammation in rheumatoid arthritis: the role of physical activity.

Authors:  George S Metsios; Antonios Stavropoulos-Kalinoglou; Aamer Sandoo; Jet J C S Veldhuijzen van Zanten; Tracey E Toms; Holly John; George D Kitas
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

10.  A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis.

Authors:  Rogelio Palomino-Morales; Carlos Gonzalez-Juanatey; Tomas R Vazquez-Rodriguez; Luis Rodriguez; Jose A Miranda-Filloy; Benjamin Fernandez-Gutierrez; Javier Llorca; Javier Martin; Miguel A Gonzalez-Gay
Journal:  Arthritis Res Ther       Date:  2010-04-26       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.